Four Small-Cap Stocks Report New Developments...

Naples, United States, September 24th, 2026, FinanceWire

Change Agents Corp. (Nasdaq: CHGA) develops agentic AI software, meaning AI tools that can carry out tasks on their own with little hands-on direction. Its lineup includes Beacon, an AI search optimization platform, and Catch-Up, an AI video studio built for podcasters, influencers, and other digital creators. The company has also moved into one of the fastest-growing corners of defense tech: counter-drone systems.

Change Agents recently announced the launch of Autonomous Air Defense LLC, a wholly owned subsidiary that will pursue AI-enabled drone surveillance and counter-unmanned aerial systems (C-UAS) technology for defense, homeland security, and critical infrastructure customers. Alongside the launch, the company added retired Major General Malcolm Frost to its advisory board. Frost spent 31 years in the U.S. Army, served as Deputy Commanding General of the 82nd Airborne Division, and deployed to Bosnia, Iraq, and Afghanistan.

The market behind that move is big and growing fast. MarketsandMarkets valued the global counter-UAS market at $6.6 billion in 2025 and projects it will reach $20.3 billion by 2030, a compound annual growth rate of about 25%.

Change Agents has kept the news coming since. It joined the Institute for Defense and Government Advancement (IDGA) and plans to take part in IDGA's Counter UAS Summit, putting the company in the room with military stakeholders and defense tech companies. It was also accepted into the Seagate Partner Program, which gives it access to Seagate's product information, training, and partner resources as it evaluates the data storage and computing needs of AI-driven autonomous systems.

On the software side, Change Agents recently announced it completed Phase 2 of Catch-Up. The work was done with Caylent, an AWS Premier Tier Services Partner, and funded by an AWS grant. Phase 2 turned Catch-Up into an agentic video studio built to generate personalized short-form videos on its own and distribute them across social platforms. The company said beta testing is expected to begin in September 2026.

Change Agents Corp. (Nasdaq: CHGA) maintains an estimated public float of under 1 million shares out of its approximately 1.05 million total shares outstanding following its recent capital restructuring.The company continues to advance updates across both counter-drone defense and agentic AI as it expands its operational footprint.

This positions CHGA as a key micro-cap to follow in the AI and defense sectors. The company is building in two fast-moving areas, counter-drone defense and agentic AI, and it keeps putting out updates on both fronts.

Quoin Pharmaceuticals Ltd. (Nasdaq: QNRX) is a late clinical-stage specialty pharmaceutical company developing treatments for rare and orphan diseases. Its lead drug, QRX003, is a topical treatment being studied in Netherton Syndrome, a rare genetic skin disorder with no FDA-approved treatment, along with several other rare skin conditions.

Quoin recently reported positive interim data from its Phase 2/3 study of QRX003 in Netherton Syndrome. Four of the first six participants, or 66.7%, improved by at least one grade on the Investigator Global Assessment at Week 12, meeting the study's primary endpoint with statistical significance. All three participants who started with moderate to severe itching saw clinically meaningful improvement, and no treatment-related serious adverse events were reported. The same day, Quoin announced a private placement of up to $50 million from healthcare-focused institutional investors. The company said the money could fund operations into the second half of 2029 if all warrants are exercised.

Following the announcement, Quoin Pharmaceuticals (Nasdaq: QNRX) saw increased trading activity, with shares reaching $7.41 in premarket trading compared to a previous close of $5.16

It wasn't the first time. In November 2025, Quoin shares surged 66% in premarket trading after the company hit its target drug loadings for its topical rapamycin formulations.

The news has kept coming. The FDA has since granted QRX003 a second Rare Pediatric Disease designation, this time for Peeling Skin Syndrome. If QRX003 is approved, Quoin could become eligible for Priority Review Vouchers, and the company estimates two vouchers could carry a combined value of more than $300 million. Lake Street has also initiated coverage with a Buy rating.

Quoin's developments illustrate the market response that can occur when a specialty pharmaceutical firm pair positive clinical data with new institutional backing, driving a notable shift in trading volume.

Myseum.AI, Inc. (Nasdaq: MYSE) is a privacy-focused technology company. Its main product is Picture Party, a private social networking app with encrypted galleries, curated albums, and controlled sharing, available on iOS and Google Play. The company also runs DatChat Messenger, which lets users control how long their messages stay visible and blocks screenshots.

In April, the company announced it had rebranded from Myseum, Inc. to Myseum.AI to reflect the privacy-first AI built into its platforms. The market responded right away. After closing around $1.50 the session before, shares traded as high as $5.77.

Since then, the company has lined up a string of AI partners. Days after the rebrand, Myseum.AI was accepted into the AMD AI Developer Program, which provides AMD Developer Cloud credits, tools, and training. In June, it signed a non-binding letter of intent with Scanon.ai Systems to add privacy-first AI and computer vision features to Picture Party, including content moderation and automated scene classification. Shares rose 17% in after-hours trading on that news. In July, Amazon Web Services committed to fund part of the development of an AI album creation and media management tool for Picture Party, with AWS Premier Partner Caylent leading the build.

Most recently, Myseum.AI announced a partnership with Fujifilm North America to bring print-on-demand products, from photo prints to canvas and gifts, into the Picture Party app. CEO Darin Myman called it "an important new revenue opportunity for the company."

With approximately 5.2 million shares outstanding, Myseum.AI continues to focus on securing technology integration partnerships across the AI sector.

Linkers Industries Ltd. (Nasdaq: LNKS) makes wire and cable harnesses, the bundled wiring that carries power and signals through cars, industrial equipment, and home appliances. The company operates in Malaysia, Thailand, Switzerland, and the U.S. and sells to manufacturers in the automotive, industrial, and home appliance markets.

In June, Linkers announced a definitive agreement to raise its stake in LPW Electronics, a Thailand-based wire harness maker, from 20% to up to 49%. The deal covers another 29% of LPW for about $2.35 million, plus roughly $6.16 million in cash to settle amounts LPW owed to an associate. LPW runs a 6,500-square-meter factory and warehouse in Pathum Thani, Thailand, and serves multinational customers mainly in the automotive and industrial sectors. Linkers said the deal would help grow its customer base and expand its footprint in Thailand.

With approximately 1.36 million Class A shares outstanding, Linkers Industries experienced heightened trading activity, with shares reaching $2.12 in after-hours trading following the announcement. Following the transaction announcement, Linkers Industries (Nasdaq: LNKS) experienced heightened trading volume, opening at $2.99 compared to a previous close of $1.60, before reaching an intraday high of $4.98 and closing the session at $2.57

This wasn't the first time an LPW deal moved the stock. When Linkers first agreed to buy its original 20% stake in LPW in October 2025, shares rose about 30% on the news.

Disclaimers:

RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Change Agents Corp to assist in the production and distribution of content related to CHGA. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. 

About RazorPitch

RazorPitch is an investor relations and investor marketing firm specializing in Non-Traditional Investor Relations for public companies. RazorPitch complements traditional IR with digital-first investor visibility, retail investor engagement, and ongoing investor communications.

razorpitch.com

Contact